, nécessité de recours à l'hémodialyse et à la ventilation mécanique ainsi que l'absence de plasmaphérèse sont les facteurs pronostiques associés au décès chez les patients anti-MBG

E. W. Goodpasture, Landmark publication from The American Journal of the Medical Sciences: The significance of certain pulmonary lesions in relation to the etiology of influenza, Am J Med Sci. août, vol.338, issue.2, pp.148-51, 2009.

M. C. Stanton and J. D. Tange, Goodpasture's syndrome (pulmonary haemorrhage associated with glomerulonephritis), Australas Ann Med. mai, vol.7, issue.2, pp.132-176, 1958.

R. L. Scheer, Immune Aspects of the Glomerulonephritis Associated with Pulmonary Hemmorhage, Annals of Internal Medicine. 1 juin, vol.60, issue.6, p.1009, 1964.

R. A. Lerner, R. J. Glassock, and F. J. Dixon, The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis, J Exp Med. 1 déc, vol.126, issue.6, pp.989-1004, 1967.

J. C. Jennette, R. J. Falk, P. A. Bacon, N. Basu, M. C. Cid et al., revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides, vol.65, pp.1-11, 2012.

N. A. Kefalides, A collagen of unusual composition and a glycoprotein isolated from canine glomerular basement membrane, Biochem Biophys Res Commun. 4 janv, vol.22, issue.1, pp.26-32, 1966.

B. G. Hudson, K. Tryggvason, M. Sundaramoorthy, and E. G. Neilson, Alport's syndrome, Goodpasture's syndrome, and type IV collagen, N Engl J Med. 19 juin, vol.348, issue.25, pp.2543-56, 2003.

J. Saus, J. Wieslander, J. P. Langeveld, S. Quinones, and B. G. Hudson, Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV, J Biol Chem. 15 sept, vol.263, issue.26, pp.13374-80, 1988.

K. O. Netzer, A. Leinonen, A. Boutaud, D. B. Borza, P. Todd et al., The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17-31 and 127-141 of the NC1 domain, J Biol Chem. 16 avr, vol.274, issue.16, pp.11267-74, 1999.

V. Pedchenko, O. Bondar, A. B. Fogo, R. Vanacore, P. Voziyan et al.,

, Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis, N Engl J Med. 22 juill, vol.363, issue.4, pp.343-54, 2010.

R. W. Steblay, Glomerulonephritis induced in sheep by injections of heterologous glomerular basement membrane and Freund's complete adjuvant, J Exp Med. 1 août, vol.116, pp.253-72, 1962.

M. Segelmark, R. Butkowski, and J. Wieslander, Antigen restriction and IgG subclasses among anti-GBM autoantibodies, Nephrol Dial Transplant, vol.5, issue.12, pp.991-997, 1990.

J. Zhao, Y. Yan, Z. Cui, R. Yang, and M. Zhao, The immunoglobulin G subclass distribution of anti-GBM autoantibodies against rHalpha3(IV)NC1 is associated with disease severity, Hum Immunol. juin, vol.70, issue.6, pp.425-434, 2009.

Z. Cui and M. Zhao, Avidity of anti-glomerular basement membrane autoantibodies was associated with disease severity, Clin Immunol. juill, vol.116, issue.1, pp.77-82, 2005.

C. B. Wilson and F. J. Dixon, Anti-glomerular basement membrane antibody-induced glomerulonephritis, Kidney Int. févr, vol.3, issue.2, pp.74-89, 1973.

J. B. Levy, R. H. Lachmann, and C. D. Pusey, Recurrent Goodpasture's disease, Am J Kidney Dis. avr, vol.27, issue.4, pp.573-581, 1996.

B. Y. Choy, T. M. Chan, and K. N. Lai, Recurrent glomerulonephritis after kidney transplantation, Am J Transplant. nov, vol.6, issue.11, pp.2535-2577, 2006.

F. E. Nolasco, J. S. Cameron, B. Hartley, A. Coelho, G. Hildreth et al.,

, Intraglomerular T cells and monocytes in nephritis: study with monoclonal antibodies, Kidney Int. mai, vol.31, issue.5, pp.1160-1166, 1987.

E. G. Dean, G. Wilson, M. Li, K. L. Edgtton, K. M. O'sullivan et al.,

, Experimental autoimmune Goodpasture's disease: a pathogenetic role for both effector cells and antibody in injury, Kidney Int. févr, vol.67, issue.2, pp.566-75, 2005.

J. Wu, J. Hicks, J. Borillo, W. F. Glass, and Y. Lou, CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis, J Clin Invest. févr, vol.109, issue.4, pp.517-541, 2002.

J. Zou, S. Hannier, L. S. Cairns, R. N. Barker, A. J. Rees et al., Healthy individuals have Goodpasture autoantigen-reactive T cells, J Am Soc Nephrol. févr, vol.19, issue.2, pp.396-404, 2008.

C. J. Derry, C. N. Ross, G. Lombardi, P. D. Mason, A. J. Rees et al., Analysis of T cell responses to the autoantigen in Goodpasture's disease, Clin Exp Immunol. mai, vol.100, issue.2, pp.262-270, 1995.

S. W. Olson, C. B. Arbogast, T. P. Baker, D. Owshalimpur, D. K. Oliver et al.,

, Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease, J Am Soc Nephrol, vol.22, issue.10, pp.1946-52, 2011.

A. Xenocostas, S. Jothy, B. Collins, R. Loertscher, and M. Levy, Anti-glomerular basement membrane glomerulonephritis after extracorporeal shock wave lithotripsy, Am J Kidney Dis. janv, vol.33, issue.1, pp.128-160, 1999.

V. Guerin, C. Rabian, L. H. Noel, D. Droz, C. Baron et al., Anti-glomerularbasement-membrane disease after lithotripsy, Lancet. 7 avr, vol.335, issue.8693, pp.856-863, 1990.

A. D. Salama, A. N. Chaudhry, K. A. Holthaus, K. Mosley, R. Kalluri et al.,

, Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease. Kidney Int, vol.64, pp.1685-94, 2003.

A. D. Salama, A. N. Chaudhry, J. J. Ryan, E. Eren, J. B. Levy et al.,

, Goodpasture's disease, CD4(+) T cells escape thymic deletion and are reactive with the autoantigen alpha3(IV)NC1, J Am Soc Nephrol. sept, vol.12, issue.9, pp.1908-1923, 2001.

M. Canney, P. V. O'hara, C. M. Mcevoy, S. Medani, D. M. Connaughton et al.,

, Spatial and Temporal Clustering of Anti-Glomerular Basement Membrane Disease, Clin J Am Soc Nephrol. 8 août, vol.11, issue.8, pp.1392-1401, 2016.

J. J. Mcphaul and J. D. Mullins, Glomerulonephritis mediated by antibody to glomerular basement membrane. Immunological, clinical, and histopathological characteristics, J Clin Invest. févr, vol.57, issue.2, pp.351-61, 1976.

D. M. Taylor, M. Yehia, I. J. Simpson, H. Thein, Y. Chang et al., Anti-glomerular basement membrane disease in Auckland, Intern Med J. juin, vol.42, issue.6, pp.672-678, 2012.

K. Hirayama, K. Yamagata, M. Kobayashi, and A. Koyama, Anti-glomerular basement membrane antibody disease in Japan: part of the nationwide rapidly progressive glomerulonephritis survey in Japan, Clin Exp Nephrol, vol.12, issue.5, pp.339-386, 2008.

F. K. Li, K. C. Tse, M. F. Lam, T. Yip, S. L. Lui et al., Incidence and outcome of antiglomerular basement membrane disease in Chinese, Nephrology

C. D. Pusey, Anti-glomerular basement membrane disease, Kidney Int, vol.64, issue.4, pp.1535-50, 2003.

S. R. Williamson, C. L. Phillips, S. P. Andreoli, and C. Nailescu, A 25-year experience with pediatric anti-glomerular basement membrane disease, Pediatr Nephrol. janv, vol.26, issue.1, pp.85-91, 2011.

Z. Cui, J. Zhao, X. Jia, S. Zhu, and M. Zhao, Clinical features and outcomes of antiglomerular basement membrane disease in older patients, Am J Kidney Dis. avr, vol.57, issue.4, pp.575-82, 2011.

Z. Cui, J. Zhao, X. Jia, S. Zhu, J. Q. Cheng et al., Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center Chinese cohort study, Medicine (Baltimore). sept, vol.90, issue.5, pp.303-314, 2011.

C. O. Savage, C. D. Pusey, C. Bowman, A. J. Rees, and C. M. Lockwood, Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4, Br Med J (Clin Res Ed). 1 févr, vol.292, issue.6516, pp.301-305, 1986.

E. G. Fischer and D. J. Lager, Anti-glomerular basement membrane glomerulonephritis: a morphologic study of 80 cases, Am J Clin Pathol. mars, vol.125, issue.3, pp.445-50, 2006.

G. O. Perez, S. Bjornsson, A. H. Ross, J. Aamato, N. Rothfield et al.,

, Goodpasture's syndrome clinical and immunological studies, Nephron, vol.13, issue.2, pp.161-73, 1974.

C. B. Wilson and R. C. Smith, Goodpasture's syndrome associated with influenza A2 virus infection, Ann Intern Med. janv, vol.76, issue.1, pp.91-95, 1972.

Q. Gu, L. Xie, X. Jia, R. Ma, Y. Liao et al., Fever and prodromal infections in anti-glomerular basement membrane disease, Nephrology (Carlton). mai, vol.23, issue.5, pp.476-82, 2018.

M. R. Clatworthy, E. F. Wallin, and D. R. Jayne, Anti-glomerular basement membrane disease after alemtuzumab, N Engl J Med. 14 août, vol.359, issue.7, pp.768-777, 2008.

M. Fisher, C. D. Pusey, R. W. Vaughan, and A. J. Rees, Susceptibility to anti-glomerular basement membrane disease is strongly associated with HLA-DRB1 genes, Kidney Int. janv, vol.51, issue.1, pp.222-231, 1997.

R. Yang, Z. Cui, J. Zhao, and M. Zhao, The role of HLA-DRB1 alleles on susceptibility of Chinese patients with anti-GBM disease, Clin Immunol, vol.133, issue.2, pp.245-50, 2009.

X. Zhou, J. Lv, D. Bu, L. Yu, Y. Yang et al., Copy number variation of FCGR3A

, rather than FCGR3B and FCGR2B is associated with susceptibility to anti-GBM disease, Int Immunol. janv, vol.22, issue.1, pp.45-51, 2010.

U. Persson, J. M. Hertz, M. Carlsson, T. Hellmark, I. Juncker et al., Patients with Goodpasture's disease have two normal COL4A3 alleles encoding the NC1 domain of the type IV collagen alpha 3 chain, Nephrol Dial Transplant. août, vol.19, issue.8, pp.2030-2035, 2004.

A. Greco, M. I. Rizzo, D. Virgilio, A. Gallo, A. Fusconi et al.,

, Goodpasture's syndrome: a clinical update, Autoimmun Rev. mars, vol.14, issue.3, pp.246-53, 2015.

F. Dammacco, S. Battaglia, L. Gesualdo, and V. Racanelli, Goodpasture's disease: a report of ten cases and a review of the literature, Autoimmun Rev. sept, vol.12, issue.11, pp.1101-1109, 2013.

R. Lazor, L. Bigay-gamé, V. Cottin, J. Cadranel, O. Decaux et al.,

, Alveolar hemorrhage in anti-basement membrane antibody disease: a series of 28 cases, Medicine (Baltimore). mai, vol.86, issue.3, pp.181-93, 2007.

J. C. Jennette, Rapidly progressive crescentic glomerulonephritis, Kidney Int. mars, vol.63, issue.3, pp.1164-77, 2003.

D. C. Kluth and A. J. Rees, Anti-glomerular basement membrane disease, J Am Soc Nephrol. nov, vol.10, issue.11, pp.2446-53, 1999.

K. Andrassy, S. Küster, R. Waldherr, and E. Ritz, Rapidly progressive glomerulonephritis: analysis of prevalence and clinical course, Nephron, vol.59, issue.2, pp.206-218, 1991.

W. Tang, S. P. Mcdonald, C. M. Hawley, S. V. Badve, N. C. Boudville et al.,

, Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease, Kidney Int. mars, vol.83, issue.3, pp.503-513, 2013.

J. B. Levy, A. N. Turner, A. J. Rees, and C. D. Pusey, Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression

, Ann Intern Med. 5 juin, vol.134, issue.11, pp.1033-1075, 2001.

J. C. Jennette and D. B. Thomas, Crescentic glomerulonephritis, Nephrol Dial Transplant, vol.16, issue.6, pp.80-82, 2001.

J. De-zoysa, D. Taylor, H. Thein, and M. Yehia, Incidence and features of dual anti-GBMpositive and ANCA-positive patients. Nephrology (Carlton), vol.16, pp.725-734, 2011.

D. R. Jayne, P. D. Marshall, S. J. Jones, and C. M. Lockwood, Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis, Kidney Int. mars, vol.37, issue.3, pp.965-70, 1990.

C. A. Verburgh, J. A. Bruijn, M. R. Daha, and L. A. Van-es, Sequential development of anti-GBM nephritis and ANCA-associated Pauci-immune glomerulonephritis, Am J Kidney Dis. août, vol.34, issue.2, pp.344-352, 1999.

T. Hellmark, J. L. Niles, A. B. Collins, R. T. Mccluskey, and C. Brunmark,

, GBM antibodies in sera with or without ANCA, J Am Soc Nephrol. mars, vol.8, issue.3, pp.376-85, 1997.

J. Li, Z. Cui, J. Wang, S. Hu, X. Jia et al., Autoantibodies against Linear Epitopes of Myeloperoxidase in Anti-Glomerular Basement Membrane Disease, Clin J Am Soc Nephrol. 7 avr, vol.11, issue.4, pp.568-75, 2016.

J. B. Levy, T. Hammad, A. Coulthart, T. Dougan, and C. D. Pusey, Clinical features and outcome of patients with both ANCA and anti-GBM antibodies, Kidney Int, vol.66, issue.4, pp.1535-1575, 2004.

X. Bosch, E. Mirapeix, J. Font, X. Borrellas, R. Rodríguez et al.,

, Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease, Clin Nephrol. sept, vol.36, issue.3, pp.107-120, 1991.

B. Alchi, M. Griffiths, M. Sivalingam, J. D. Farrington, and K. , Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort

, Nephrol Dial Transplant. mai, vol.30, issue.5, pp.814-835, 2015.

S. P. Mcadoo, A. Tanna, Z. Hru?ková, L. Holm, M. Weiner et al.,

, Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients, Kidney Int, vol.92, issue.3, pp.693-702, 2017.

C. M. Lockwood, A. J. Rees, T. A. Pearson, D. J. Evans, D. K. Peters et al.,

, Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome, Lancet. 3 avr, vol.1, issue.7962, pp.711-716, 1976.

I. J. Simpson, P. B. Doak, L. C. Williams, H. A. Blacklock, R. S. Hill et al., Plasma exchange in Goodpasture's syndrome, Am J Nephrol, vol.2, issue.6, pp.301-312, 1982.

A. Huart, A. Josse, D. Chauveau, J. Korach, F. Heshmati et al.,

, Outcomes of patients with Goodpasture syndrome: A nationwide cohort-based study from the French Society of Hemapheresis, J Autoimmun, vol.73, pp.24-33, 2016.

P. Biesenbach, R. Kain, K. Derfler, T. Perkmann, A. Soleiman et al.,

, Long-term outcome of anti-glomerular basement membrane antibody disease treated with immunoadsorption, PLoS ONE, vol.9, issue.7, p.103568, 2014.

Y. Zhang, Z. Tang, D. Chen, D. Gong, J. D. Liu et al., Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis, BMC Nephrol. 3 août, vol.15, p.128, 2014.

K. De-groot, L. Harper, D. Jayne, F. Suarez, L. F. Gregorini et al.,

, Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial, Ann Intern Med. 19 mai, vol.150, issue.10, pp.670-80, 2009.

M. Touzot, J. Poisson, S. Faguer, D. Ribes, P. Cohen et al., Rituximab in anti-GBM disease: A retrospective study of 8 patients, J Autoimmun. juin, vol.60, pp.74-83, 2015.

L. Balke, M. Both, A. Arlt, M. Rosenberg, and B. Bewig, Severe adult respiratory distress syndrome from Goodpasture syndrome. Survival using extracorporeal membrane oxygenation, Am J Respir Crit Care Med. 15 janv, vol.191, issue.2, pp.228-237, 2015.

D. G. Herbert, H. Buscher, and P. Nair, Prolonged venovenous extracorporeal membrane oxygenation without anticoagulation: a case of Goodpasture syndrome-related pulmonary haemorrhage, Crit Care Resusc. mars, vol.16, issue.1, pp.69-72, 2014.

D. Borza, M. F. Chedid, S. Colon, D. J. Lager, N. Leung et al.,

, Goodpasture's disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1/alpha2 chains of type IV collagen, Am J Kidney Dis. févr, vol.45, issue.2, pp.397-406, 2005.

N. B. Bowley, R. E. Steiner, and W. S. Chin, The chest X-ray in antiglomerular basement membrane antibody disease (Goodpasture's syndrome), Clin Radiol. juill, vol.30, issue.4, pp.419-448, 1979.

B. R. Burke and R. A. Bear, Recurrent Goodpasture's syndrome, Can Med Assoc J, vol.129, issue.9, pp.978-987, 1983.

C. Daly, P. J. Conlon, W. Medwar, and J. J. Walshe, Characteristics and outcome of antiglomerular basement membrane disease: a single-center experience, Ren Fail. janv, vol.18, issue.1, pp.105-117, 1996.

F. C. Fervenza, D. Terreros, A. Boutaud, B. G. Hudson, R. A. Williams et al.,

, Recurrent Goodpasture's disease due to a monoclonal IgA-kappa circulating antibody, Am J Kidney Dis. sept, vol.34, issue.3, pp.549-55, 1999.

C. R. Hind, C. Bowman, C. G. Winearls, and C. M. Lockwood, Recurrence of circulating antiglomerular basement membrane antibody three years after immunosuppressive treatment and plasma exchange, Clin Nephrol. avr, vol.21, issue.4, pp.244-250, 1984.

R. Kalluri, K. Meyers, A. Mogyorosi, M. P. Madaio, and E. G. Neilson, Goodpasture syndrome involving overlap with Wegener's granulomatosis and anti-glomerular basement membrane disease, J Am Soc Nephrol, vol.8, issue.11, pp.1795-800, 1997.

R. J. Klasa, R. T. Abboud, H. S. Ballon, and L. Grossman, Goodpasture's syndrome: recurrence after a five-year remission. Case report and review of the literature, Am J Med. avr, vol.84, issue.4, pp.751-756, 1988.

P. S. Mehler, M. W. Brunvand, M. P. Hutt, and R. J. Anderson, Chronic recurrent Goodpasture's syndrome, Am J Med. avr, vol.82, issue.4, pp.833-838, 1987.

A. J. Rees, C. M. Lockwood, and D. K. Peters, Enhanced allergic tissue injury in Goodpasture's syndrome by intercurrent bacterial infection, Br Med J. 17 sept, vol.2, issue.6089, pp.723-729, 1977.

K. Laczika, S. Knapp, K. Derfler, A. Soleiman, W. H. Hörl et al., Immunoadsorption in Goodpasture's syndrome, Am J Kidney Dis. août, vol.36, issue.2, pp.392-397, 2000.

J. D. Briggs and E. Jones, Scientific Advisory Board of the ERA-EDTA Registry. European Renal Association-European Dialysis and Transplant Association, Nephrol Dial Transplant. mars, vol.14, issue.3, pp.570-575, 1999.

F. L. Benoit, D. B. Rulon, G. B. Theil, P. D. Doolan, R. H. Watten et al., Am J Med. sept, vol.37, pp.424-468, 1964.

A. J. Proskey, L. Weatherbee, R. E. Easterling, J. A. Greene, and J. M. Weller, Goodpasture's syndrome. A report of five cases and review of the literature, Am J Med. févr, vol.48, issue.2, pp.162-73, 1970.

S. P. Mcadoo and C. D. Pusey, Anti-Glomerular Basement Membrane Disease, Clin J Am Soc Nephrol. 7 juill, vol.12, issue.7, pp.1162-72, 2017.

C. Pagnoux and L. Guillevin, Rituximab or azathioprine maintenance in ANCA-associated vasculitis, N Engl J Med, vol.22, issue.4, pp.386-393, 2015.

, Regression Modeling Strategies -With Applications to Linear Models, Logistic

S. Regression, |. Harrell, and . Springer,

D. Sur,

J. Reynolds, G. A. Preston, B. M. Pressler, P. Hewins, M. Brown et al.,

, Autoimmunity to the alpha 3 chain of type IV collagen in glomerulonephritis is triggered by « autoantigen complementarity, J Autoimmun. mai, vol.59, pp.8-18, 2015.

J. H. Stone, P. A. Merkel, R. Spiera, P. Seo, C. A. Langford et al., Rituximab versus cyclophosphamide for ANCA-associated vasculitis, N Engl J Med. 15 juill, vol.363, issue.3, pp.221-253, 2010.

P. Charles, A. Néel, N. Tieulié, A. Hot, G. Pugnet et al., Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients, Rheumatology (Oxford). mars, vol.53, issue.3, pp.532-541, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01064298

L. Guillevin, C. Pagnoux, A. Karras, C. Khouatra, O. Aumaître et al.,

, Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis, N Engl J Med, vol.371, pp.1771-80, 2014.

Y. Shah, A. Mohiuddin, C. Sluman, I. Daryanani, T. Ledson et al.,

, Rituximab in anti-glomerular basement membrane disease, QJM. févr, vol.105, issue.2, pp.195-202, 2012.

S. P. Mcadoo, J. Reynolds, G. Bhangal, J. Smith, J. P. Mcdaid et al., Spleen tyrosine kinase inhibition attenuates autoantibody production and reverses experimental autoimmune GN, J Am Soc Nephrol, vol.25, issue.10, pp.2291-302, 2014.

S. P. Mcadoo, G. Bhangal, T. Page, H. T. Cook, C. D. Pusey et al., Correlation of disease activity in proliferative glomerulonephritis with glomerular spleen tyrosine kinase expression, Kidney Int. juill, vol.88, issue.1, pp.52-60, 2015.

R. Yang, M. A. Otten, T. Hellmark, C. M. Björck, L. Zhao et al., Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes, Nephrol Dial Transplant. août, vol.25, issue.8, pp.2479-86, 2010.